Vertex on track for “five launches in five disease areas over a five-year period” through emerging pain and renal franchises.

Lower risk for foot disease driven by lower risk for neuropathy for new users of SGLT-2 inhibitors versus GLP-1 receptor agonists.

Patients and physicians often both play a role when a patient’s treatment stalls. There are ways to prevent it.

Drivers could be hit with £1,000 fine for wrongly declaring their condition and may also face prosecution in the event of an ...